Atherosclerosis and the two faces of endothelial nitric oxide synthase

RMF Wever, TF Lüscher, F Cosentino, TJ Rabelink - Circulation, 1998 - Am Heart Assoc
that enhanced peroxynitrite formation occurs in atherosclerosis and could contribute to lipid
peroxidation in atherosclerosis. 24, 51 Taken together, these data indicate that catabolism of …

Human endothelial cells bioactivate organic nitrates to nitric oxide: implications for the reinforcement of endothelial defence mechanisms

M Feelisch, F Brands, M Kelm - European journal of clinical …, 1995 - Wiley Online Library
Although in therapeutic use for more than a century, the mode of cellular action of organic
nitrates remains incompletely understood. Despite ample experimental evidence from …

[HTML][HTML] Endothelium-derived nitric oxide as an antiatherogenic mechanism: implications for therapy

RA Sukhovershin, G Yepuri… - Methodist DeBakey …, 2015 - ncbi.nlm.nih.gov
Endothelium-derived nitric oxide (eNO) is a multifunctional signaling molecule critically
involved in the maintenance of metabolic and cardiovascular homeostasis. In addition to its …

Statin-stimulated nitric oxide release from endothelium.

LW Dobrucki, L Kalinowski, IT Dobrucki… - … Medical Journal of …, 2001 - europepmc.org
Background There is increasing evidence that loss of endothelium-derived NO is a major
factor in cardiovascular complication events, and that NO might exert antiatherosclerotic …

The role of nitric oxide in the post-ischemic revascularization process

DL Contreras, HV Robles, E Romo, A Rios… - Pharmacology & …, 2006 - Elsevier
Following arterial occlusion, blood vessels respond by sprouting new capillaries (ie
angiogenesis) and by growing and remodelling pre-existing arterioles into physiologically …

Nitric oxide and oxidative stress in vascular disease

U Förstermann - Pflügers Archiv-European Journal of Physiology, 2010 - Springer
Endothelium-derived nitric oxide (NO) is a paracrine factor that controls vascular tone,
inhibits platelet function, prevents adhesion of leukocytes, and reduces proliferation of the …

S-Nitrosothiols: a class of nitric oxide-donor drugs

H Al-Sa'Doni, A Ferro - Clinical science, 2000 - portlandpress.com
Nitric oxide (NO) was originally described as the principal endothelium-derived relaxing
factor, but it is now known to subserve a variety of functions throughout the body, both …

Nitric oxide, a protective molecule in the cardiovascular system

J Lei, Y Vodovotz, E Tzeng, TR Billiar - Nitric Oxide, 2013 - Elsevier
Nitric oxide (NO) is an intra-and inter-signaling molecule that regulates vessel dilatation,
neuronal transmission, cardiac contraction, immunomodulation, and stem cell differentiation …

Cardiovascular diseases and the nitric oxide pathway

S Llorens, E Nava - Current vascular pharmacology, 2003 - ingentaconnect.com
Fifteen years after its discovery, NO has fully reached an established position in physiology,
medicine and therapeutics. It is difficult to find a biological function or a pathological …

Nitric oxide donors: biochemical pharmacology and therapeutics

JA Bauer, BP Booth, HL Fung - Advances in pharmacology, 1995 - Elsevier
Publisher Summary The nitric oxide (NO) donors are a diverse group of agents with unique
chemical structures and biochemical requirements for generation of NO. The diverse and …